XELOX与FOLFOX6方案一线治疗晚期结直肠癌的近期疗
效及不良反应比较
祖恩霞;蒋锦龙
【期刊名称】《延边医学》 【年(卷),期】2015(000)006
【摘要】目的：：比较分析XELOX与FOLFOX6一线治疗晚期结直肠癌的近期疗效以及不良反应情况。方法：选取我院收治的40例晚期结直肠癌患者为研究对象，将其随机分为A组和B组，每组各20例，A组患者采用XELOX（卡培他滨联合奥沙利铂）方案治疗，B组患者采FOLFOX6（亚叶酸钙（CF）、5-氟尿嘧啶（5-FU）联合奥沙利铂）方案治疗，对比两组患者的疗效和不良反应。结果：A组患者治疗有效率为50.0%，B组为45.0%，两组差异不具显著性（P>0.05）。A组患者中性粒细胞减少、神经毒性、血小板减少发生率明显低于B组（P<0.05），而手足综合征的发生率则明显高于B组（P<0.05）。结论：XELOX和FOLFOX6方案治疗晚期结直肠癌的近期疗效方面无显著差异，而前者比后者用药更为方便，且不良反应情况整体优于后者，有更高的临床应用价值。%objective:comparative analysis of XELOX and FOLFOX6 first-line treatment of advanced colorectal cancer in the near future curative effect and adverse reactions. Methods:40 cases of patients with advanced colorectal cancer to select our hospital as the re-search object, its were randomly divided into group A and group B, 20 cases in each group, A group of patients using XELOX (capecitabine in combination with oxaliplatin into) solution treatment, the patients in group B
FOLFOX6 (calcium leucovorin (CF), 5-fluorouracil (5 FU) in combination with oxaliplatin into) solution treatment, compared two groups of curative effect and adverse reaction of patients. Results:the patients of group A treatment effective rate of 50.0%, B group was 45.0%, has no significant difference in the two groups (P>0.05). A group of patients with neutropenia, neurotoxicity, the incidence of thrombocytopenia was lower than that in group B (P<0.05), while the incidence of hand, foot and syndrome is significantly higher than group B (P<0.05). Conclusion:FOLFOX6 scheme and XELOX short-term curative effect on the treatment of advanced colorectal cancer has no significant difference, while the former drug use is more convenient than the latter, and adverse reaction conditions overall superior to the latter, has a higher clinical value. 【总页数】3页(197-199)
【关键词】晚期结直肠癌;卡培他滨;奥沙利铂 【作者】祖恩霞;蒋锦龙
【作者单位】安徽省淮南市东方医院集团广济医院三病区232001;安徽省淮南市东方医院集团肿瘤医院内一病区 232001 【正文语种】中文 【中图分类】 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_yanbian-
medicine_thesis/0201264675974.html 【相关文献】
1.XELOX 与 FOLFOX6方案一线治疗晚期结直肠癌的近期疗效及不良反应比较 [J], 马妮娜; 王婧; 李卉惠; 张瑞雪; 曹邦伟
2.XELOX与FOLFOX6方案一线治疗晚期结直肠癌的近期疗效及不良反应比较 [J], 罗永忠; 欧阳周
3.FOLFOX4方案与XELOX方案治疗转移性结直肠癌的疗效与不良反应分析 [J], 黄芳; 刘超英
4.XELOX与FOLFOX4方案一线治疗晚期结直肠癌的近期疗效及毒副反应比较 [J], 张茹霞; 陶敏; 段卫明; 王振欣; 王蓉
5.XELOX方案与FOLFOX4方案治疗晚期结直肠癌疗效比较 [J], 杨兰; 邓颖; 胡洪林; 潘海霞
以上内容为文献基本信息，获取文献全文请下载
XELOX与FOLFOX6方案一线治疗晚期结直肠癌的近期疗效及不良反应比较
